POTENTIAL OF IMIPENEM AS SINGLE-AGENT EMPIRIC ANTIBIOTIC-THERAPY OF FEBRILE NEUTROPENIC PATIENTS WITH CANCER

被引：59
|
作者：
WADE, JC
STANDIFORD, HC
DRUSANO, GL
JOHNSON, DE
MOODY, MR
BUSTAMANTE, CI
JOSHI, JH
DEJONGH, C
SCHIMPFF, SC
机构：
[1] UNIV MARYLAND,SCH MED,DEPT MED,DIV INFECT DIS,BALTIMORE,MD 21201
[2] VET ADM MED CTR,BALTIMORE,MD 21218
来源：
AMERICAN JOURNAL OF MEDICINE | 1985年 / 78卷 / 6A期
关键词：
D O I：
10.1016/0002-9343(85)90103-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：62 / 72
页数：11
相关论文
共 50 条
  • [1] EMPIRIC SINGLE AGENT OR COMBINATION ANTIBIOTIC-THERAPY FOR FEBRILE EPISODES IN NEUTROPENIC PATIENTS - AN OVERVIEW
    LIESCHKE, GJ
    BELL, D
    RAWLINSON, W
    GREEN, MD
    SHERIDAN, W
    MORSTYN, G
    STUARTHARRIS, R
    KEFFORD, RF
    LEVI, J
    SORRELL, T
    FOX, RM
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 : S37 - S42
  • [2] IMIPENEM AS SINGLE-AGENT ANTIBIOTIC-THERAPY FOR POSTCESAREAN INFECTION
    PASTOREK, JG
    FARO, S
    ALDRIDGE, KE
    GRAFFEO, S
    MCKENNA, CC
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1986, 40 (01): : 225 - 231
  • [3] OVERVIEW OF EMPIRIC ANTIBIOTIC-THERAPY FOR THE FEBRILE NEUTROPENIC PATIENT
    SCHIMPFF, SC
    REVIEWS OF INFECTIOUS DISEASES, 1985, 7 : S734 - S740
  • [4] POTENTIAL OF MEZLOCILLIN AS EMPIRIC SINGLE-AGENT THERAPY IN FEBRILE GRANULOCYTOPENIC CANCER-PATIENTS
    WADE, JC
    SCHIMPFF, SC
    NEWMAN, KA
    FORTNER, CL
    MOODY, MR
    YOUNG, VM
    WIERNIK, PH
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (02) : 299 - 306
  • [5] DURATION OF ANTIBIOTIC-THERAPY IN FEBRILE NEUTROPENIC PATIENTS
    LEYLAND, MJ
    CLOUGH, JV
    FARRELL, IA
    WOOD, MJ
    CLINICAL SCIENCE, 1984, 67 : P53 - P53
  • [6] MEZLOCILLIN - SINGLE AGENT AS EMPIRIC ANTIBIOTIC-THERAPY
    WADE, JC
    SCHIMPFF, SC
    NEWMAN, KA
    FORTNER, CL
    MOODY, MR
    YOUNG, VM
    WIERNIK, PH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 94 - 94
  • [7] COMPARISON OF CEFOPERAZONE AND MEZLOCILLIN WITH IMIPENEM AS EMPIRIC THERAPY IN FEBRILE NEUTROPENIC CANCER-PATIENTS
    MORTIMER, J
    MILLER, S
    BLACK, D
    KWOK, K
    KIRBY, WM
    AMERICAN JOURNAL OF MEDICINE, 1988, 85 (1A): : 17 - 20
  • [8] THE EFFECT OF DIFFERENT MEASURES OF OUTCOME ON THE RESULTS OF STUDIES OF EMPIRIC ANTIBIOTIC-THERAPY IN FEBRILE NEUTROPENIC PATIENTS
    ELLIOTT, CR
    PATER, JL
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1988, 11 (05): : 327 - 330
  • [9] AN EVALUATION OF EMPIRICAL ANTIBIOTIC-THERAPY IN FEBRILE NEUTROPENIC PATIENTS
    BARNES, RA
    ROGERS, TR
    BRITISH JOURNAL OF HAEMATOLOGY, 1987, 66 (01) : 137 - 140
  • [10] STRATEGY FOR ANTIBIOTIC-THERAPY IN FEBRILE NEUTROPENIC PATIENTS ON SELECTIVE ANTIBIOTIC DECONTAMINATION
    DEMARIE, S
    VANDENBROEK, PJ
    WILLEMZE, R
    VANFURTH, R
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (12) : 897 - 906
12345